THE USE OF DIFFERENT HES SOLUTIONS AS AN ONCOTIC SUBSTANCE IN PERITONEAL-DIALYSIS

被引:0
|
作者
LUKASEWITZ, P [1 ]
FORSTER, H [1 ]
机构
[1] UNIV FRANKFURT KLINIKUM,TECH EXPTL ANASTHESIOL ABT,W-6000 FRANKFURT 70,GERMANY
关键词
PERITONEAL DIALYSIS; HYDROXYETHYL STARCH; TISSUE STORAGE; PLASMA ELIMINATION;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In 272 nephrectomised rats, 3% hydroxyethyl starch solutions (310 mOsm/l) were compared with colloid-free 2% dextrose solutions as peritoneal dialysis fluid. With regard to effectiveness of dialysis and the rate of ultrafiltration there was no significant difference between the hydroxyethyl starch und dextrose solutions. The oncotic pressure was raised in the peritoneal cavity and the decrease of loss of protein was expected. Nevertheless this could be verified. In all rats dialysed with HES there was an increase of serum concentration of HES and a progressive accumulation of the colloid in different organs (liver, lung, spleen). The lower substituted molecules (40/0,5; 200/0,5) were able to pass the peritoneum more readily than the higher substituted HES molecules (70/0,7; 450/0,7). A further interesting finding was that the elimination rate of HES from the intravascular space is influenced to a greater deal by its degree of substitution than by its molecular weight.
引用
收藏
页码:622 / 629
页数:8
相关论文
共 50 条
  • [21] STABILITY OF CEFAZOLIN SODIUM IN PERITONEAL-DIALYSIS SOLUTIONS
    NAHATA, MC
    AHALT, PA
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1991, 48 (02): : 291 - 292
  • [22] SYMPOSIUM ON THE BIOCOMPATIBILITY OF PERITONEAL-DIALYSIS SOLUTIONS - INTRODUCTION
    OREOPOULOS, DG
    BREBOROWICZ, A
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 1995, 15 (07): : S4 - S4
  • [23] EFFECT OF DIFFERENT PERITONEAL-DIALYSIS SOLUTIONS ON THE FUNCTION OF HUMAN PERITONEAL-MACROPHAGES (PMO) INVITRO
    ANDRE, M
    EGLE, B
    ATMANSPACHER, R
    SCHOLLMEYER, P
    LUBRICHBIRKNER, I
    STEINHAUER, HB
    [J]. KIDNEY INTERNATIONAL, 1993, 44 (01) : 251 - 252
  • [24] ACETATE VERSUS LACTATE IN PERITONEAL-DIALYSIS SOLUTIONS
    PEDERSEN, FB
    RYTTOV, N
    DELEURAN, P
    DRAGSHOLT, C
    KILDEBERG, P
    [J]. NEPHRON, 1985, 39 (01): : 55 - 58
  • [25] STABILITY OF DOBUTAMINE HYDROCHLORIDE IN PERITONEAL-DIALYSIS SOLUTIONS
    GORA, ML
    SETH, S
    VISCONTI, JA
    SHIELDS, B
    BAY, W
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1991, 48 (06): : 1234 - 1237
  • [26] STABILITY OF CIPROFLOXACIN INJECTION IN PERITONEAL-DIALYSIS SOLUTIONS
    KANE, MP
    BAILIE, GR
    MOON, DG
    SIU, I
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (03): : 373 - 377
  • [27] LACTATE-CONTAINING PERITONEAL-DIALYSIS SOLUTIONS
    ING, TS
    ZHOU, XJ
    YU, AW
    ZHOU, FQ
    VAZIRI, ND
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1993, 16 (10): : 688 - 693
  • [28] COMPOSITION OF PERITONEAL-DIALYSIS SOLUTIONS - POTENTIAL HAZARDS
    HENDERSON, IS
    [J]. BLOOD PURIFICATION, 1989, 7 (2-3) : 86 - 94
  • [29] STABILITY OF COMBINATIONS OF ANTIBIOTICS IN PERITONEAL-DIALYSIS SOLUTIONS
    WEIJERS, TF
    FIEREN, MWJA
    WAGENVOORT, JHT
    [J]. PERITONEAL DIALYSIS BULLETIN, 1984, 4 (01): : 52 - 53
  • [30] STABILITY OF CEFOTAXIME IN 2 PERITONEAL-DIALYSIS SOLUTIONS
    PAAP, CM
    NAHATA, MC
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (01): : 147 - 150